B. Vijayaraghavan

As Senior Vice President of Strategy, Portfolio and Business Development at Glenmark Pharmaceuticals Inc., USA, Vijay is responsible for managing Glenmark’s product portfolio in support of the company’s long term strategic plan.

Prior to joining Glenmark, Vijay worked for several leading generic drug manufacturers including Sun Pharmaceuticals, Aurobindo and Sandoz, where he held roles with increasing responsibility over RD, portfolio, business development, project management and global intellectual property. Vijay holds a doctorate in synthetic organic chemistry from the University of Delhi.